Related Experiment Video
Updated: May 23, 2026
One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
The Multi-Omic Approach to Newborn Screening: Opportunities and Challenges
Alex J Ashenden1, Ayesha Chowdhury2, Lucy T Anastasi2
1Department of Biochemical Genetics, SA Pathology, Women's and Children's Hospital, Adelaide, SA 5006, Australia.
Insights
Newborn screening can expand using multi-omic technologies like genomics and metabolomics for broader condition detection and lifelong care. Integrating these approaches addresses limitations and improves newborn health outcomes.
Area of Science:
- Genomics
- Metabolomics
- Newborn Screening
Background:
- Newborn screening programs have evolved over 60 years to detect treatable conditions early.
- Technological advancements have expanded the scope of conditions screened.
- Current screening can be broadened using omic technologies.
Purpose of the Study:
- To explore the integration of untargeted metabolomics and genomics into newborn screening.
- To discuss the potential of multi-omic approaches for expanding screened conditions and enabling lifelong care.
- To review the challenges and opportunities of implementing multi-omic newborn screening.
Main Methods:
- Review of genomic screening potential, including whole-genome sequencing.
- Discussion of metabolomics for identifying disease phenotypes and biomarkers.
- Exploration of combining complementary multi-omic strategies.
Main Results:
- Genomic screening offers lifelong care possibilities but faces implementation barriers (cost, acceptance, scalability).
- Metabolomics provides insights into disease phenotypes and biomarker discovery.
- Multi-omic approaches can leverage the strengths of both genomics and metabolomics.
Conclusions:
- Integrating multi-omic technologies presents an exciting opportunity to enhance newborn screening.
- This approach can overcome individual technique limitations and improve newborn health.
- Further research is needed for the routine adoption of multi-omic-based newborn screening.
Abstract:
Newborn screening programs have seen significant evolution since their initial implementation more than 60 years ago, with the primary goal of detecting treatable conditions within the earliest possible timeframe to ensure the optimal treatment and outcomes for the newborn. New technologies have driven the expansion of screening programs to cover additional conditions. In the current era, the breadth of screened conditions could be further expanded by integrating omic technologies such as untargeted metabolomics and genomics. Genomic screening could offer opportunities for lifelong care beyond the newborn period. For genomic newborn screening to be effective and ready for routine adoption, it must overcome barriers such as implementation cost, public acceptability, and scalability. Metabolomics approaches, on the other hand, can offer insight into disease phenotypes and could be used to identify known and novel biomarkers of disease. Given recent advances in metabolomic technologies, alongside advances in genomics including whole-genome sequencing, the combination of complementary multi-omic approaches may provide an exciting opportunity to leverage the best of both approaches and overcome their respective limitations. These techniques are described, along with the current outlook on multi-omic-based NBS research.
